MARS Bioimaging - About the company
MARS Bioimaging is a series A company based in Christchurch (New Zealand), founded in 2007. It operates as a Spectral molecular imaging technology. MARS Bioimaging has raised $15.4M in funding from Pacific Channel and Powerhouse Ventures. The company has 29 active competitors, including 9 funded and 4 that have exited. Its top competitors include companies like CurveBeam AI, Koning and Perfint Healthcare.
Company Details
Mars Bioimaging develops spectral molecular imaging technology. Based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. Products include a CT scanner, detector and visualization system.
- Website
- www.marsbioimaging.com/
- Registered Address
- 29a Clyde Road, Ilam, Christchurch, 8041 , New Zealand
Key Metrics
Founded Year
2007
Location
Christchurch, New Zealand
Stage
Series A
Total Funding
$15.4M in 2 rounds
Latest Funding Round
Investors
Ranked
4th among 29 active competitors
Employee Count
25 as on Jun 30, 2026
Similar Companies
Legal entities associated with MARS Bioimaging
MARS Bioimaging is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Mars Bioimaging Ltd. CIN: 1971549 , New Zealand, Active | Sep 09, 2007 | - | - | |
MARS Bioimaging Ltd CIN: 1743357 , United States, Active | $1 - $1M (As on Jun 07, 2018) | - | - |
Sign up to download MARS Bioimaging's company profile
MARS Bioimaging's funding and investors
MARS Bioimaging has raised a total funding of $15.4M over 2 rounds. Its first funding round was on Feb 25, 2014. Its latest funding round was a Series A round on Jan 14, 2026 for $*****. 1 investor participated in its latest round. MARS Bioimaging has 5 institutional investors and 37 angel investors.
Here is the list of recent funding rounds of MARS Bioimaging:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 14, 2026 | 9079896 | Series A | 1488659 | 7939876 | 7324141 | 3599590 |
Feb 25, 2014 | 4361508 | Series A | 2067965 | 7509170 | 5025285 |
View details of MARS Bioimaging's funding rounds and investors
MARS Bioimaging's founders and board of directors
Founder? Claim ProfileMARS Bioimaging's Board of Directors
MARS Bioimaging's board has 3 active members. Phil Butler, Colin Dawson and Anthony Philip Howard Butler are part of team.Here is the list of MARS Bioimaging's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
iicskcc | Team | - | Current | 4y 5m |
tedeask | Team | - | Current | 3y 5m |
ertp{rk | Team | - | Current | 2y 5m |
MARS Bioimaging's employee count trend
MARS Bioimaging has 25 employees as of Jun 26. Here is MARS Bioimaging's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
MARS Bioimaging's Competitors and alternates
Top competitors of MARS Bioimaging include CurveBeam AI, Koning and Perfint Healthcare. Here is the list of Top 10 competitors of MARS Bioimaging, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CurveBeam AI 2009, Melbourne (Australia), Public | Developer of AI-powered CT imaging solutions | $25.3M | 57/100 | |
2nd | Koning 2002, United States, Funding Raised | Innovating breast imaging with advanced 3D CT technology | - | 54/100 | |
3rd | Perfint Healthcare 2005, Chennai (India), Series D | Developer of solutions for image-guided interventional procedures | $41.5M | 54/100 | |
4th | MARS Bioimaging 2007, Christchurch (New Zealand), Series A | Spectral molecular imaging technology | $15.4M | 53/100 | |
5th | Developer of therapy-assist CT system for minimally invasive interventions | $8.4M | 52/100 | ||
6th | Adiposs 2018, Geneva (Switzerland), Series A | Developer of medical imaging equipment for the diagnosis of cachexia | $7.25M | 51/100 | |
7th | Neurologica 2004, Danvers (United States), Acquired | Mobile imaging solutions transforming point-of-care diagnostics and improving patient outcomes | $17M | - | 47/100 |
8th | Vivosight 2006, Maidstone (United Kingdom), Series B | Provider of optical coherence tomography diagnostic device for dermatology | $8.9M | 47/100 | |
9th | Mobius Imaging 2008, Shirley (United States), Acquired | Intra-operative imaging solutions for demanding surgical requirements, enhancing surgical precision | $82M | 44/100 | |
10th | Xoran Technologies 2001, Ann Arbor (United States), Early Stage | Innovating low-dose CT imaging solutions for human and veterinary point-of-care | $4M | 40/100 |
Looking for more details on MARS Bioimaging's competitors? Click here to see the top ones
MARS Bioimaging's Investments and acquisitions
MARS Bioimaging has made no investments or acquisitions yet.
News related to MARS Bioimaging
Media has covered MARS Bioimaging for a total of 2 events in the last 1 year.
•
MARS Bioimaging Secures $15 Million to Expand Spectral Photon-Counting CT Imaging GloballyAPPLIED RADIOLOGY•Jan 15, 2026•MARS Bioimaging, Pacific Channel
Are you a Founder ?
FAQs about MARS Bioimaging
Explore our recently published companies
- Otzarreta Think And Make - Gipuzkoa based, 1970 founded, Unfunded company
- Accelerate360Canada - Burlington based, 1969 founded, Acquired company
- Mabsolutions - Darmstadt based, Funding Raised company
- Synscribe - Singapore based, 2025 founded, Unfunded company
- Native Ecology - Denver based, 2000 founded, Funding Raised company
- MackyClyde SEO - Bangsar based, 2020 founded, Unfunded company